SPN-810 Failure

Quote












anonymous said:
To play devils advocate, long term successful companies have been built on much less. Things aren’t great as of late but you can’t say that we haven’t done pretty well for “just a XR company.”

If 812 goes as planned, and I understand that’s a bigger “if” now than it was before, but if it does then in a few years we are sitting on a pile of cash that makes $800M look like chump change. Then we can go acquire the means to other growth opportunities. That’s how this business works.

If you disagree, that’s you’re right and I don’t blame you. The way I see it, right now this is an investment where there are really only 2 options:

1. If you think Supernus goes to zero or our best days are behind us then you leave. If you leave though, you have to be OK with missing out on the future growth(career, equity, etc) if it goes the other way.

OR

2. If you think this is a short term setback in the long term plan of a healthy company then you stay. But, similar to option 1, if you stay you have to be OK with the risk that it goes south.

It’s that simple. No one can’t fault you for taking either route. Just don’t stick around and be a non-contributor.
Click to expand...

The leader of a well organized cult, If you ever come across "The Chad" count your lucky stars cause there's only one out there. Moving forward I designate thee "The Chad" as we all know that you are not drinking the Kool Aid yourself but are administering the IV Solution to anyone you can chain down. Nothing consensual about "The Chad".

I know you are likely viewed as a legend in your small circle but I see nothing but a Nacha. So keep hanging around, we know you really serve no known purpose, more often than not on a hot day when walking around you just get sweaty and irritated and have to cover yourself with Gold Bond to get through the day.
 






anonymous said:
The leader of a well organized cult, If you ever come across "The Chad" count your lucky stars cause there's only one out there. Moving forward I designate thee "The Chad" as we all know that you are not drinking the Kool Aid yourself but are administering the IV Solution to anyone you can chain down. Nothing consensual about "The Chad".

I know you are likely viewed as a legend in your small circle but I see nothing but a Nacha. So keep hanging around, we know you really serve no known purpose, more often than not on a hot day when walking around you just get sweaty and irritated and have to cover yourself with Gold Bond to get through the day.
Click to expand...
Cult is a good way to describe this place. And please be more specific about which Chad. This company is a pyramid hierarchy of Chads. Chads all around. Everyone’s so friendly sure, yet it is odd that they all say the same exact thing, with well practiced sincerity. Like robots. Very very creepy
 


















anonymous said:
So what does this press release about 810 mean for us? They are still going to try to seek approval?
Click to expand...

This is very good news. As expected the results that we saw reported from P301 was found out to be a reason outside of the drugs efficacy. Study design is a critical factor and 6 to 7 patients out of only 135 not fitting into the ITT population will sway results and will dilute the P value. Supernus’ 810 team has worked on this project for over 10 years and with this positive news, contrary to the naysayers, will be a project that we will keep investing into. We will see the results for the adolescent study 1Q 2020 and will have a clearer picture on how the company is going to proceed.
 






anonymous said:
This is very good news. As expected the results that we saw reported from P301 was found out to be a reason outside of the drugs efficacy. Study design is a critical factor and 6 to 7 patients out of only 135 not fitting into the ITT population will sway results and will dilute the P value. Supernus’ 810 team has worked on this project for over 10 years and with this positive news, contrary to the naysayers, will be a project that we will keep investing into. We will see the results for the adolescent study 1Q 2020 and will have a clearer picture on how the company is going to proceed.
Click to expand...

Please stop throwing good money after bad.
 






anonymous said:
This is very good news. As expected the results that we saw reported from P301 was found out to be a reason outside of the drugs efficacy. Study design is a critical factor and 6 to 7 patients out of only 135 not fitting into the ITT population will sway results and will dilute the P value. Supernus’ 810 team has worked on this project for over 10 years and with this positive news, contrary to the naysayers, will be a project that we will keep investing into. We will see the results for the adolescent study 1Q 2020 and will have a clearer picture on how the company is going to proceed.
Click to expand...

Very well said. Originally I viewed 810 as dead after the first phase 3 topline data was released. But now think it's closer to 50 50. The 2nd phase 3 will show us how the company will procede.
 






anonymous said:
This is very good news. As expected the results that we saw reported from P301 was found out to be a reason outside of the drugs efficacy. Study design is a critical factor and 6 to 7 patients out of only 135 not fitting into the ITT population will sway results and will dilute the P value. Supernus’ 810 team has worked on this project for over 10 years and with this positive news, contrary to the naysayers, will be a project that we will keep investing into. We will see the results for the adolescent study 1Q 2020 and will have a clearer picture on how the company is going to proceed.
Click to expand...

Naysayer here. Is it too much to ask for you guys to live in reality? Start thinking about how you can give the field a viable product instead of running down this rabbit hole that leads to yet another mission impossible for the field to overcome. 810 is dead, the quicker you can acknowledge that the quicker we can move towards being a healthy company again.

MOVE ON!!
 






look at that- more ignorant opinions from 20-something reps presented as fact. How many times do these ridiculous comments need to be proven wrong before you realize people just laugh at you. At least this time it’s a subject that reps know a lot about- drug development! Seriously- get over yourself
 






anonymous said:
look at that- more ignorant opinions from 20-something reps presented as fact. How many times do these ridiculous comments need to be proven wrong before you realize people just laugh at you. At least this time it’s a subject that reps know a lot about- drug development! Seriously- get over yourself
Click to expand...

Last I checked us 20 something reps are far from responsible for the stock being in freefall. I guess that would fall on the shoulders of drug development and management. You can discredit us all you want but you are the one that looks stupid right now.
 






Stay focused. The post said you are always wrong with this stuff so why should we continue to listen? Your response: “well you guys suck”!
Like talking to a 7-year old that has nothing of real value to contribute to an adult conversation
 












Still waiting to raise my hand to be a leader in Canada to share the truly unbelievable benefits our meds bring to the table. Changing lives! Let’s go international!!!!!!!

oh wait. They don’t, so I guess it’s just US only. Hmmmm
 






























Going to go out on a limb and guess you won’t be missed, in performance or otherwise. But why wait? Why not leave now? Oh right- you are too stupid to realize you can quit and still get paid out on your vacation time
 






Top Bottom
Back
Quote